NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation
- 1 October 2019
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 383 (1) , 111488
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81370794, 81570604, 81770666)
- Shanghai Municipal Commission of Health and Family Planning, and Office for Traditional Chinese Medicine Development of Shanghai (ZHYY-ZXYJHZX-1-02)
- Shanghai Municipal Commission of Health and Family Planning (20134095)
This publication has 34 references indexed in Scilit:
- Cisplatin nephrotoxicity: a review of the literatureJournal Of Nephrology, 2017
- Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration DataAmerican Journal of Kidney Diseases, 2016
- Tubular Epithelial NF-κB Activity Regulates Ischemic AKIJournal of the American Society of Nephrology, 2016
- Renal Hemodynamics in AKIJournal of the American Society of Nephrology, 2016
- An integrated view of cisplatin-induced nephrotoxicity and ototoxicityToxicology Letters, 2015
- Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKDNature Reviews Nephrology, 2015
- Hypoxia as a key player in the AKI-to-CKD transitionAmerican Journal of Physiology-Renal Physiology, 2014
- Acute kidney injury and chronic kidney disease: an integrated clinical syndromeKidney International, 2012
- Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injuryNature Medicine, 2010
- Acute kidney injury: a springboard for progression in chronic kidney diseaseAmerican Journal of Physiology-Renal Physiology, 2010